Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.

MLA

Hsieh, Ching-Hung, et al. “Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.” Cancers, vol. 14, no. 2, Feb. 2022, p. 294. EBSCOhost, https://doi.org/10.3390/cancers14020294.

APA

Hsieh, C.-H., Jian, C.-Z., Lin, L.-I., Low, G.-S., Ou, P.-Y., Hsu, C., & Ou, D.-L. (2022). Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer. Cancers, 14(2), 294. https://doi.org/10.3390/cancers14020294

Chicago

Hsieh, Ching-Hung, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, and Da-Liang Ou. 2022. “Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.” Cancers 14 (2): 294. doi:10.3390/cancers14020294.